SHEILA GUJRATHI
CIK 1575202 · President & CEO · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.30M
Companies
7
Total Filings
33
Lifetime Open-Market Net
-$8.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Director | 0 | $13.99 | $0 | -$3.07M | 11 | 2026-03-04 |
| JANX | Director | 118,889 | $13.56 | $1.61M | $0 | 6 | 2025-06-13 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 2 | 2020-06-17 |
| GOSS | President & CEO | 4,237,742 | $0.16 | $686.1K | $168.0K | 4 | 2020-02-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 3 | 2018-05-14 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 1 | 2015-12-03 |
| Receptos, Inc. (RCPT) Delisted | Chief Medical Officer | 12,500 | — | — | -$5.11M | 6 | 2015-08-27 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-24 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-26 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2019-02-12 | GOSS | Conv (C) | +62,030 | $0 | EDGAR |
| 2018-05-14 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-12 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-23 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-03 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-08-27 | Receptos, Inc. (RCPT) Delisted | Mixed | −133,161 | $0 | EDGAR |
| 2015-04-03 | Receptos, Inc. (RCPT) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2014-11-12 | Receptos, Inc. (RCPT) Delisted | Sell (S) | −30,000 | -$3.27M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.